Funds holding Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
ISIN CNE1000051X5 · China
- Fund holders
- 3
- Of which ETFs
- 2 1 other fund
- Value held
- 155.4K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 19,761 | 86K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 8,321 | 36.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 7,621 | 33.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 3 | -5 | 35,703 | -70.8 % |
| 2026Q1 | 8 | -1 | 122,314 | -18.0 % |
| 2025Q4 | 9 | -2 | 149,081 | -65.3 % |
| 2025Q3 | 11 | -1 | 430,097 | -14.2 % |
| 2025Q2 | 12 | +2 | 501,184 | +4.4 % |
| 2025Q1 | 10 | +1 | 479,832 | +1.5 % |
| 2024Q4 | 9 | +5 | 472,634 | +851.2 % |
| 2024Q3 | 4 | +3 | 49,688 | +596.6 % |
| 2024Q2 | 1 | 7,133 |
Cite this page
Titelia. "Funds holding Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.". https://titelia.com/en/stocks/jiangsu-sinopep-allsino-biopharmaceutical-co-ltd-CNE1000051X5